Isoray Completes Merger with Viewpoint Molecular Targeting to Treatment Paradigm
06 Feb 2023 //
BUSINESSWIRE
Viewpoint Molecular Targeting Announces First Neuroendocrine Tumor Patients
23 Jan 2023 //
BUSINESSWIRE
Isoray & Viewpoint Molecular Announce Investor Webcast on October 19, 2022
18 Oct 2022 //
BUSINESSWIRE
Viewpoint Molecular Targeting Announces Transformational Merger
29 Sep 2022 //
BIOSPACE
Viewpoint Molecular Targeting Announces Publication of Preclinical Data of VMT01
24 Sep 2021 //
BIOSPACE
Viewpoint MolecularTargeting Receives Clearance of IND Application for VMT-a-NET
09 Sep 2021 //
BIOSPACE
Viewpoint Molecular Targeting Commences Patient Enrollment for VMT01 Program
10 Jun 2021 //
ACCESSWIRE